Natalia Chunga1, Anthony E Lang2, Karlo J Lizarraga3,4. 1. Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA. 2. Division of Neurology, Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, University of Toronto, Toronto, Ontario, Canada. 3. Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA. karlo.lizarraga@gmail.com. 4. Motor Physiology and Neuromodulation Program, Division of Movement Disorders and Center for Health and Technology (CHeT), Department of Neurology, University of Rochester, Rochester, New York, USA. karlo.lizarraga@gmail.com.
Authors: Karlo J Lizarraga; David Adams; M Judith D Post; Jay Skyler; Carlos Singer Journal: Parkinsonism Relat Disord Date: 2017-03-18 Impact factor: 4.891
Authors: Karlo J Lizarraga; Natalia Chunga; Nicolas A Yannuzzi; Harry W Flynn; Carlos Singer; Anthony E Lang Journal: Parkinsonism Relat Disord Date: 2020-10-13 Impact factor: 4.891